Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | arginase 2 mitochondrial | 0.2231 | 0.5 | 0.5 |
Trichomonas vaginalis | Arginase, putative | 0.2231 | 0.5 | 0.5 |
Leishmania major | arginase | 0.2231 | 0.5 | 0.5 |
Schistosoma mansoni | arginase | 0.2231 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.2231 | 0.5 | 0.5 |
Plasmodium vivax | arginase, putative | 0.2231 | 0.5 | 0.5 |
Plasmodium falciparum | arginase | 0.2231 | 0.5 | 0.5 |
Entamoeba histolytica | Arginase, putative | 0.2231 | 0.5 | 0.5 |
Echinococcus multilocularis | 0.2231 | 0.5 | 0.5 | |
Echinococcus multilocularis | arginase 2, mitochondrial | 0.2231 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.2231 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | > 50 ug ml-1 | Antifungal activity against Candida albicans after 48 hrs by broth microdilution assay | ChEMBL. | 21130651 |
MIC (functional) | > 50 ug ml-1 | Antifungal activity against Candida albicans MTCC-183 after 48 hrs by broth microdilution assay | ChEMBL. | 21130651 |
MIC (functional) | = 50 ug ml-1 | Antifungal activity against Candida albicans isolate CDRI after 48 hrs by broth microdilution assay | ChEMBL. | 21130651 |
MIC (functional) | > 50 ug ml-1 | Antifungal activity against Candida albicans NCIM-3557 after 48 hrs by broth microdilution assay | ChEMBL. | 21130651 |
MIC (functional) | > 200 ug ml-1 | Antitrichomonas activity against Trichomonas vaginalis after 48 hrs by trypan blue exclusion assay | ChEMBL. | 21130651 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.